2006 proposed fee schedule - American Society of Clinical Oncology

2006 proposed fee schedule - American Society of Clinical Oncology 2006 proposed fee schedule - American Society of Clinical Oncology

19.02.2013 Views

The revisions read as follows: §413.174 Prospective rates for hospital-based and independent ESRD facilities. * * * * * 370 (f) Additional payment for separately billable drugs. CMS makes an additional payment for certain drugs furnished to ESRD patients by a Medicare-approved ESRD facility. CMS makes this payment directly to the ESRD facility. Payment for these drugs is made-- (1) Only on an assignment basis, directly to the facility which must accept, as payment in full, the amount that CMS determines; (2) Subject to the Part B deductible and coinsurance; (3) To hospital-based facilities in accordance with the cost reimbursement rules set forth in this part, except for erythropoietin/epogen (commonly called EPO), which is paid the same amount as independent facilities; and (4) To independent facilities in accordance with the methodology set forth in §405.517 of this chapter. 12. Section 413.180 is amended by-- A. Revising paragraphs (b) and (d) B. Removing paragraphs (e) and (k). C. Redesignationg paragraphs (f) through (j) as paragraphs (e) through (i).

371 D. Redesignating paragraphs (l) and (m) as paragraphs (j) and (k). The amendment reads as follows: §413.180 Procedures for requesting exceptions to payment rates. * * * * * (b) Criteria for requesting an exception. If a pediatric ESRD facility projects on the basis of prior year costs and utilization trends that it has an allowable cost per treatment higher than its prospective rate set under §413.174, and if these excess costs are attributable to one or more of the factors in §413.182, the facility may request, in accordance with paragraph (e) of this section, that CMS approve an exception to that rate and set a higher prospective payment rate. * * * * * (d) Payment rate exception request. Effective October 1, 2002, CMS may approve exceptions to a pediatric ESRD facility’s updated prospective payment rate, if the pediatric ESRD facility did not have an approved exception rate as of October 1, 2002. A pediatric ESRD facility may request an exception to its payment rate at any time after it is in operation for at least 12 consecutive months. * * * * * 13. Section 413.182 is revised to read as follows:

371<br />

D. Redesignating paragraphs (l) and (m) as paragraphs<br />

(j) and (k).<br />

The amendment reads as follows:<br />

§413.180 Procedures for requesting exceptions to payment<br />

rates.<br />

* * * * *<br />

(b) Criteria for requesting an exception. If a<br />

pediatric ESRD facility projects on the basis <strong>of</strong> prior year<br />

costs and utilization trends that it has an allowable cost<br />

per treatment higher than its prospective rate set under<br />

§413.174, and if these excess costs are attributable to one<br />

or more <strong>of</strong> the factors in §413.182, the facility may<br />

request, in accordance with paragraph (e) <strong>of</strong> this section,<br />

that CMS approve an exception to that rate and set a higher<br />

prospective payment rate.<br />

* * * * *<br />

(d) Payment rate exception request. Effective<br />

October 1, 2002, CMS may approve exceptions to a pediatric<br />

ESRD facility’s updated prospective payment rate, if the<br />

pediatric ESRD facility did not have an approved exception<br />

rate as <strong>of</strong> October 1, 2002. A pediatric ESRD facility may<br />

request an exception to its payment rate at any time after<br />

it is in operation for at least 12 consecutive months.<br />

* * * * *<br />

13. Section 413.182 is revised to read as follows:

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!